Boston, MA -- (SBWIRE) -- 09/04/2015 -- Artificial organs are human-made bio-artificial devices, which are implanted or integrated into individuals to replace or support natural organs. These include artificial heart, kidney, pancreas, and cochlear implants. Biocompatible materials such as polymers (polyurethane, polysulfone, and porous polypropylene), biologics, ceramics, and metals are used to develop artificial organs. These organs are incorporated with different technologies like sensors, biomaterials, and innovative delivery systems. Artificial organs perform the function of the natural organ and help in extending a patient's lifespan. In few cases, artificial organs are capable of eliminating the need for organ transplantation altogether.

Technavio's analysts forecast the global artificial organ market to grow at a CAGR of 7.99% over the period 2014-2019.

Commenting on the report, an analyst from Technavio's team said: "The electronic insulin pump calculates blood sugar automatically, making it convenient to use. It also enables the user to eat and sleep comfortably, without complications. Thus, they are considered a standard and easy option to treat diabetes, resulting in increased acceptance and preference over traditional treatment methods such as self-monitoring and herbal medicines."

Get More Details on this Report and a Full Table of Contents at Global Artificial Organ Market 2015-2019

According to the report, ESRD is the last stage of chronic kidney disease. At the end of 2014, approximately 3,200,000 patients, worldwide, were treated for ESRD, and this number is expected to increase by 6% every year. Kidney diseases in individuals who are obese, have uncontrolled high blood pressure and cholesterol levels, and consume tobacco are more likely to progress to ESRD. The disease is most prevalent in adults over 60 years of age, who are prone to age-related kidney failure. The improvement in access to dialysis treatment correlates with the number of patients requiring care.

Further, the report states that we expect the high cost of artificial organs to hinder market growth.

The key players in the Global Artificial Organ Market are Baxter, Cochlear, Fresenius, SynCardia and Medtronic while other prominent vendors include Animas, Argon Medical Devices, Asahi Kasei Medical, B. Braun, C.R. Bard, Chongqing Shanwaishan, Covidien, DaVita, F. Hoffmann-La Roche, Insulet, Jihua Medical, Kawasumi Laboratories, Medical Components, Merit Medical Systems, Neurelec, Nikkiso, Nipro, Nurotron Biotechnology, NxStage Medical, SOOIL Development and Tandem Diabetes Care

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. For further information on this report, please visit - http://www.technavio.com/report/artificial-organ-market

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Healthcare research reports at Fast Market Research

You may also be interested in these related reports:

- Global Sensory Organ Partnering 2010-2015: Deal trends, players and financials
- Global Organ Preservation Solutions Market 2014-2018
- Global Transplantation Market 2015-2019
- Global Renal Dialysis Market 2014-2018
- Global Joint Reconstruction Market 2015-2019